• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对间日疟原虫再次感染人类的回顾性研究。

A retrospective examination of reinfection of humans with Plasmodium vivax.

作者信息

Collins William E, Jeffery Geoffrey M, Roberts Jacquelin M

机构信息

Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.

出版信息

Am J Trop Med Hyg. 2004 Jun;70(6):642-4.

PMID:15211006
Abstract

A retrospective examination was made of archival data collected between 1940 and 1963 to determine the impact of reinfection of patients with Plasmodium vivax with homologous and heterologous strains of the parasite. Following reinfection of 14 patients with a homologous strain, the geometric mean maximum parasite count was reduced from 9,101/microL during the primary infection to 998/microL and the geometric mean daily parasite count for the first 20 days was reduced from 923/microL to 16/microL. Following reinfection of 22 patients with heterologous strains of P. vivax, the geometric mean maximum parasite count was 8,460/microL during the primary infection versus a secondary level of 9,196/microL and the geometric mean daily parasite count decreased from 847/microL/day to 335/microL/day. Reductions in fever episodes > or =101 degrees F and > or = 104 degrees F appeared to be a more sensitive measure of clinical immunity. Fever episodes > or =104 degrees F in patients with homologous strain reinfections decreased from 1.92 episodes per week to 0.18 compared with 1.24 to 0.57 in patients with heterologous infections. Fever episodes > or =101 degrees F decreased from 2.98 to 0.60 in the homologous strain compared with 2.08 to 1.07 for the heterologous infections. The average maximum fever temperature in the homologous group was 106 degrees F during the primary infection versus 103.4 degrees F for the secondary infection compared with 105.8 degrees F during the primary infections versus 105.6 degrees F for the secondary infection in the heterologous patients.

摘要

对1940年至1963年间收集的档案数据进行了回顾性研究,以确定间日疟原虫患者再次感染同源和异源疟原虫菌株的影响。14名患者再次感染同源菌株后,几何平均最大寄生虫计数从初次感染时的9101/微升降至998/微升,前20天的几何平均每日寄生虫计数从923/微升降至16/微升。22名患者再次感染间日疟原虫异源菌株后,初次感染时的几何平均最大寄生虫计数为8460/微升,二次感染时为9196/微升,几何平均每日寄生虫计数从847/微升/天降至335/微升/天。发热发作次数≥101华氏度和≥104华氏度的减少似乎是临床免疫更敏感的指标。同源菌株再次感染患者中≥104华氏度的发热发作次数从每周1.92次降至0.18次,而异源感染患者中则从1.24次降至0.57次。同源菌株中≥101华氏度的发热发作次数从2.98次降至0.60次,而异源感染患者中则从2.08次降至1.07次。同源组初次感染时的平均最高发热温度为106华氏度,二次感染时为103.4华氏度,而异源患者初次感染时为105.8华氏度,二次感染时为105.6华氏度。

相似文献

1
A retrospective examination of reinfection of humans with Plasmodium vivax.对间日疟原虫再次感染人类的回顾性研究。
Am J Trop Med Hyg. 2004 Jun;70(6):642-4.
2
A retrospective examination of the effect of fever and microgametocyte count on mosquito infection on humans infected with Plasmodium vivax.
Am J Trop Med Hyg. 2004 Jun;70(6):638-41.
3
A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity.对先前感染过异种疟原虫的患者中恶性疟原虫子孢子和滋养体诱导感染的回顾性研究:对寄生虫学和临床免疫发展的影响。
Am J Trop Med Hyg. 1999 Jul;61(1 Suppl):36-43. doi: 10.4269/tropmed.1999.61-036.
4
Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey.土耳其间日疟原虫疟疾中的寄生虫密度和血清细胞因子水平
Parasite Immunol. 2006 May;28(5):201-7. doi: 10.1111/j.1365-3024.2006.00822.x.
5
Adaptation of Plasmodium vivax to growth in owl monkeys (Aotus nancymai).
Comp Med. 2005 Dec;55(6):528-32.
6
The Chesson strain of plasmodium vivax in humans and different species of Aotus monkeys.人源间日疟原虫Chesson株及不同种类夜猴中的该毒株。
Am J Trop Med Hyg. 2009 Jan;80(1):152-9.
7
Potential of the Panama strain of Plasmodium vivax for the testing of malarial vaccines in Aotus nancymai monkeys.间日疟原虫巴拿马株在南美白狨猴中用于测试疟疾疫苗的潜力。
Am J Trop Med Hyg. 2002 Nov;67(5):454-8. doi: 10.4269/ajtmh.2002.67.454.
8
Plasmodium simium and Saimiri boliviensis as a model system for testing candidate vaccines against Plasmodium vivax.以猕猴疟原虫和玻利维亚松鼠猴作为测试间日疟原虫候选疫苗的模型系统。
Am J Trop Med Hyg. 2005 Sep;73(3):644-8.
9
Studies on the Salvador I strain of Plasmodium vivax in non-human primates and anopheline mosquitoes.间日疟原虫萨尔瓦多I株在非人灵长类动物和按蚊中的研究。
Am J Trop Med Hyg. 2009 Feb;80(2):228-35.
10
Salvador II strain of Plasmodium vivax in Aotus monkeys and mosquitoes for transmission-blocking vaccine trials.用于传播阻断疫苗试验的食蟹猴和蚊子体内的间日疟原虫萨尔瓦多II株
Am J Trop Med Hyg. 1998 Jul;59(1):29-34. doi: 10.4269/ajtmh.1998.59.29.

引用本文的文献

1
A systematic analysis of the human immune response to Plasmodium vivax.对人类针对间日疟原虫的免疫反应的系统分析。
J Clin Invest. 2023 Oct 16;133(20):e152463. doi: 10.1172/JCI152463.
2
Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites.症状性疟疾增强了对同源疟原虫(Plasmodium falciparum)再感染的保护。
PLoS Pathog. 2023 Jun 12;19(6):e1011442. doi: 10.1371/journal.ppat.1011442. eCollection 2023 Jun.
3
Symptomatic malaria enhances protection from reinfection with homologous parasites.
有症状的疟疾可增强对同源寄生虫再感染的抵抗力。
medRxiv. 2023 Jan 5:2023.01.04.23284198. doi: 10.1101/2023.01.04.23284198.
4
Repeat controlled human malaria infection of healthy UK adults with blood-stage : Safety and parasite growth dynamics.重复对英国健康成年人进行带虫期的人体疟疾感染控制:安全性和寄生虫生长动力学。
Front Immunol. 2022 Aug 22;13:984323. doi: 10.3389/fimmu.2022.984323. eCollection 2022.
5
Recurrent Cases of Both Short and Long Latency Increased with Transmission Intensity and Were Distributed Year-Round in the Most Affected Municipalities of the RACCN, Nicaragua, 2013-2018.2013-2018 年,尼加拉瓜 RACCN 受影响最严重的城市中,短潜伏期和长潜伏期的复发病例均随着传播强度的增加而增加,并呈全年分布。
Int J Environ Res Public Health. 2022 May 19;19(10):6195. doi: 10.3390/ijerph19106195.
6
Mechanistic within-host models of the asexual Plasmodium falciparum infection: a review and analytical assessment.无性疟原虫感染的宿主内机制模型:综述与分析评估。
Malar J. 2021 Jul 10;20(1):309. doi: 10.1186/s12936-021-03813-z.
7
Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.输入的内容为:Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers. 翻译结果为:非疟疾流行地区输入性疟疾:半免疫旅行者和非免疫旅行者的比较。
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00104-19. Print 2020 Mar 18.
8
Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.疟疾控制干预措施对巴布亚新几内亚儿童中恶性疟原虫和间日疟原虫感染的差异影响。
BMC Med. 2019 Dec 9;17(1):220. doi: 10.1186/s12916-019-1456-9.
9
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens.蚊叮诱导的间日疟原虫或恶性疟原虫人工感染可引起针对同源和异源红细胞前期和红细胞期抗原的免疫应答。
Infect Immun. 2019 Feb 21;87(3). doi: 10.1128/IAI.00541-18. Print 2019 Mar.
10
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses.间日疟原虫和恶性疟原虫感染动态:再感染、复发和再燃。
Malar J. 2018 Apr 17;17(1):170. doi: 10.1186/s12936-018-2318-1.